ISSCR 2018, Melbourne, Australia June 20-23, 2018 | Booth# 83
Give your cells a competitive edge
Visit Biological Industries at Booth #83 or attend our innovation showcase to discuss your stem cell research needs and learn about our cGMP stem cell media, scale-up capabilities, and our new products and stem cell services. BI has over 35 years of experience in cell culture media development and manufacturing that uniquely positions us to support both research and cell therapy applications. Our products can give your stem cell cultures a performance advantage that results in more reliable and reproducible studies. If you’re looking for a competitive edge, Biological Industries can help.
Exhibit hours (subject to change)
Wednesday, June 20, 3:15-8:30pm
Thursday, June 21, 11am-8pm
Friday, June 22, 11am-8pm
Saturday, June 23, 11am-4pm
Innovation Showcase
Micha Druker, PhD
Helmholtz Zentrum München
Achia Urbach, PhD
Bar-Ilan University
David Fiorentini
Biological Industries
The Promise of Induced Pluripotent Stem Cells: Basic Research and Clinical grade manufacturing
Friday, June 22, 11:30 AM - 12:30 PM
Level 2, Room 212/213
Pluripotent Stem cells (PSC) research has generated tremendous excitement, and holds promise for the treatment of many uncured diseases. Early stage clinical trials using differentiated induced pluripotent stem cells (iPS) show great potential in cell-based therapeutics. Bridging the gap between research models and clinical applications is the utmost goal to ensure clinically relevant stem cell products.
In the present innovation showcase we will present a research work on SNF5 (also known as INI1 and SAMRCB1) that is one of the core subunits of the SWI/SNF chromatin-remodeling complex. Mutations in this protein might have significant effects on the epigenetic state of human embryonic stem cells and on their phenotype and precise levels of SNF5 are required in order to preserve the pluripotent state of the cells.
Critical part of the translation from research to clinical therapeutics is the generation of iPS cells, expansion, and storage of the cells under current Good Manufacturing Practice (cGMP) conditions. The innovation showcase will address the challenges related to the manufacturing of clinical grade human iPS cells including tissue biopsies, xeno-free culture procedures and raw materials, testing and cryopreservation.
Scientific Posters
A unique defined pre-coating-free culture platform for isolation and expansion of hMSC
This poster evaluates different combinations of treated plasticware (uncoated) and SF, XF MSC media. Results show that MSC NutriStem® XF (BI) together with Corning® CellBIND® (uncoated cultureware) is a superior platform for the expansion and proliferation of hMSC from a variety of sources. Read more about MSC NutriStem® XF
Expansion of pluripotent hPSC in various vitronectin-based culture systems
The poster evaluates long term expansion of hPSC using NutriStem® V9 XF on Vitronectin ACF. Results show that NutriStem® V9 XF medium enables high proliferation rate in long-term culture, while maintaining stable karyotype, high pluripotency marker expression, and preservation of tri-lineage differentiation potential of hPSC. Read more about NutriStem® V9 XF
Don't miss our HAPPY HOUR
Friday, June 22, 17:00
Stop by Booth# 83 to enjoy a refreshing cocktail and enter to win a Sony Playstation 4!
Social Media
Can't make it to ISSCR? Follow @bio_industries with #ISSCR2018 and follow us on Facebook for scientific and event updates.
